The first part of this trial, the dose escalation, is covered by the funds raised in November last year.
- Forums
- ASX - By Stock
- ATX
- Ann: Type D Meeting Outcome With US Food And Drug Administration
ATX
amplia therapeutics limited
Add to My Watchlist
12.8%
!
22.0¢

Ann: Type D Meeting Outcome With US Food And Drug Administration, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.0¢ |
Change
0.025(12.8%) |
Mkt cap ! $85.34M |
Open | High | Low | Value | Volume |
19.0¢ | 22.5¢ | 19.0¢ | $939.8K | 4.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 61514 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.215 |
2 | 273800 | 0.210 |
4 | 395000 | 0.205 |
4 | 84500 | 0.200 |
3 | 94041 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 61514 | 1 |
0.225 | 372000 | 4 |
0.230 | 223633 | 5 |
0.235 | 15000 | 1 |
0.240 | 259999 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online